2666-3503

JVS Vascular Science

Elsevier

View prefix report (10.1016)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 527 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact527 DOIs
2

Attach ORCID iDs across 406 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact406 DOIs
3

Deposit reference lists for 321 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact321 DOIs

DOIs for this ISSN

Showing the top 5 of 527 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Targeting smooth muscle cell phenotypic switching in vascula… (10.1016/j.jvssci.2021.04.001)
Abstract ORCID
112.40 176
2 Intraluminal thrombus: Innocent bystander or factor in abdom… (10.1016/j.jvssci.2021.02.001)
Abstract ORCID
89.97 62
3 Review of imaging biomarkers for the vulnerable carotid plaq… (10.1016/j.jvssci.2021.03.001)
Abstract ORCID
88.91 59
4 Machine deep learning accurately detects endoleak after endo… (10.1016/j.jvssci.2019.12.003)
Abstract ORCID
80.10 39
5 Translating mouse models of abdominal aortic aneurysm to the… (10.1016/j.jvssci.2021.01.002)
Abstract ORCID
80.10 39
6 Circulating exosomes from patients with peripheral artery di… (10.1016/j.jvssci.2020.02.001)
Abstract ORCID
77.82 35
7 Fatty acid binding protein 3 is associated with peripheral a… (10.1016/j.jvssci.2020.08.003)
Abstract ORCID
77.20 34
8 Vascular smooth muscle cell phenotype switching in carotid a… (10.1016/j.jvssci.2021.11.002)
Abstract ORCID
72.36 27
9 A histopathological classification scheme for abdominal aort… (10.1016/j.jvssci.2021.09.001)
Abstract ORCID
70.75 25
10 Inhibition of angiotensin-induced aortic aneurysm by metform… (10.1016/j.jvssci.2020.11.031)
Abstract ORCID
69.01 23
11 Six-year outcomes of a phase II study of human-tissue engine… (10.1016/j.jvssci.2022.11.001)
Abstract ORCID
68.09 22
12 Smooth muscle cells in atherosclerosis: Clones but not carbo… (10.1016/j.jvssci.2021.02.002)
Abstract ORCID
67.12 21
13 A technical and data analytic approach to pressure-volume lo… (10.1016/j.jvssci.2021.12.003)
Abstract ORCID
67.12 21
14 Thrombosis in the pathogenesis of abdominal aortic aneurysm (10.1016/j.jvssci.2023.100106)
Abstract ORCID
61.52 16
15 Transcriptomic profiling of experimental arterial injury rev… (10.1016/j.jvssci.2020.01.001)
Abstract ORCID
60.21 15
16 Proteomic analysis of descending thoracic aorta identifies u… (10.1016/j.jvssci.2022.01.001)
Abstract ORCID
60.21 15
17 Synchrotron Radiation-based X-ray phase-contrast imaging of… (10.1016/j.jvssci.2020.06.002)
Abstract ORCID
58.80 14
18 Mangiferin Conjugated Gold Nanoparticles Protect against the… (10.1016/j.jvssci.2022.05.038)
Abstract References ORCID
58.36 5
19 Increased matrix metalloproteinase 9 activity correlates wit… (10.1016/j.jvssci.2020.09.004)
Abstract ORCID
57.31 13
20 Mechanical activation of the angiotensin II type 1 receptor… (10.1016/j.jvssci.2021.07.001)
Abstract ORCID
55.70 12
21 Different Outcomes after Revascularization or Standard Super… (10.1016/j.jvssci.2020.11.019)
Abstract References ORCID
52.42 4
22 Corrugated nanofiber tissue-engineered vascular graft to pre… (10.1016/j.jvssci.2020.03.003)
Abstract ORCID
52.07 10
23 Chemical stabilization of the extracellular matrix attenuate… (10.1016/j.jvssci.2020.04.001)
Abstract ORCID
52.07 10
24 Modulation of interleukin-6 and its effect on late vein wall… (10.1016/j.jvssci.2022.04.001)
Abstract ORCID
52.07 10
25 Vascular grafts collagen coating resorption and healing proc… (10.1016/j.jvssci.2022.02.001)
Abstract ORCID
50.00 9
26 Mechanisms and efficacy of metformin-mediated suppression of… (10.1016/j.jvssci.2023.100102)
Abstract ORCID
50.00 9
27 Gangrene, revascularization, and limb function improved with… (10.1016/j.jvssci.2020.10.001)
Abstract ORCID
47.71 8
28 Imatinib attenuates neotissue formation during vascular remo… (10.1016/j.jvssci.2020.03.002)
Abstract ORCID
45.15 7
29 GSK2593074A blocks progression of existing abdominal aortic… (10.1016/j.jvssci.2020.07.001)
Abstract ORCID
45.15 7
30 Relative strain is a novel predictor of aneurysmal degenerat… (10.1016/j.jvssci.2021.08.003)
Abstract ORCID
45.15 7
31 Novel reinforcement of corrugated nanofiber tissue-engineere… (10.1016/j.jvssci.2022.01.002)
Abstract ORCID
45.15 7
32 Interleukin-6 Levels and Cardiovascular Events in the Cardio… (10.1016/j.jvssci.2022.05.039)
Abstract References ORCID
45.15 3
33 Local aortic aneurysm wall expansion measured with automated… (10.1016/j.jvssci.2021.11.004)
Abstract ORCID
42.25 6
34 Role of von Willebrand factor in venous thromboembolic disea… (10.1016/j.jvssci.2021.08.002)
Abstract
39.21 36
35 Altered hemodynamics during arteriovenous fistula remodeling… (10.1016/j.jvssci.2020.03.001)
Abstract
38.91 35
36 Distinct subsets of T cells and macrophages impact venous re… (10.1016/j.jvssci.2020.07.005)
Abstract
38.91 35
37 A versatile technique for high-resolution three-dimensional… (10.1016/j.jvssci.2020.08.001)
Abstract ORCID
38.91 5
38 K-134, a phosphodiesterase 3 inhibitor, reduces vascular inf… (10.1016/j.jvssci.2020.09.005)
Abstract ORCID
38.91 5
39 Survey of the extracellular matrix architecture across the r… (10.1016/j.jvssci.2021.08.001)
Abstract ORCID
38.91 5
40 Development of a murine iliac arteriovenous fistula model fo… (10.1016/j.jvssci.2021.09.022)
Abstract ORCID
38.91 5
41 β-Aminopropionitrile-induced aortic aneurysm and dissection… (10.1016/j.jvssci.2021.12.002)
Abstract
38.91 35
42 Validating human and mouse tissues commonly used in atherosc… (10.1016/j.jvssci.2023.100118)
Abstract ORCID
38.91 5
43 Vascular smooth muscle cell mechanotransduction through seru… (10.1016/j.jvssci.2023.100124)
Abstract ORCID
38.91 5
44 Cell-free DNA next-generation sequencing liquid biopsy as a… (10.1016/j.jvssci.2020.08.002)
Abstract
38.60 34
45 Inflammatory Activity of Human Perivascular Adipose Tissue i… (10.1016/j.jvssci.2020.11.011)
Abstract References ORCID
35.78 2
46 In Vivo Magnetic Resonance Histology of Peripheral Arterial… (10.1016/j.jvssci.2021.09.016)
Abstract References ORCID
35.78 2
47 Blockade of IL-6 Signaling Alleviates Atherosclerosis in Tet… (10.1016/j.jvssci.2023.100175)
Abstract References ORCID
35.78 2
48 Canonical transient receptor potential 6 channel deficiency… (10.1016/j.jvssci.2020.07.002)
Abstract ORCID
34.95 4
49 Evaluation of a novel hydrogel intravascular embolization ag… (10.1016/j.jvssci.2021.01.004)
Abstract ORCID
34.95 4
50 Sex differences in specialized pro-resolving lipid mediators… (10.1016/j.jvssci.2023.100107)
Abstract ORCID
34.95 4